| 000 | 00821nam a2200289 ib4500 | ||
|---|---|---|---|
| 001 | D0001B005140 | ||
| 003 | DOH | ||
| 005 | 20250131084613.0 | ||
| 008 | 250131b |||||||| |||| 00| 0 eng d | ||
| 020 |
_a9789241210256 _q(pbk.) |
||
| 022 | _a0512-3054 | ||
| 040 | _erda | ||
| 060 | 0 | _aQW 800 WHO 2019 | |
| 090 | 0 | _aQW 800 WHO 2019 | |
| 110 | 1 | _aWorld Health Organization | |
| 245 | 0 | 0 |
_aWHO Expert Committee on Biological Standardization : _bSixty-ninth report / |
| 260 |
_aGeneva : _bWorld Health Organization _c2019. |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarier _avolume |
||
| 490 |
_aWHO Technical Report Series ; _vNo. 1016 |
||
| 650 | 0 | 0 | _aBiological Products |
| 650 | 0 | 0 | _aVaccines |
| 650 | 0 | 0 | _aBlood |
| 650 | 0 | 0 | _aAnti-Bacterial Agents |
| 942 |
_2nlm _cBK |
||
| 999 |
_c6734 _d6734 |
||